GSK (GSK) total liabilities
GSK had total liabilities of £45.16B at the end of fiscal 2025 (December 31, 2025). That is 2.6% lower than the £46.38B of fiscal 2024. Figures as of 18 Nov 2026, 18:56 UTC, from Yahoo Finance.
Key facts
- Total liabilities, fiscal 2025
- £45.16B
- Change on fiscal 2024
- −2.6%
- Highest on record
- £50.05Bfiscal 2022
- Lowest on record
- £45.16Bfiscal 2025
- Fiscal years on record
- 42022–2025
Figures as of . Statements from Yahoo Finance. Amounts are in GBP. Figures, not advice.
GSK total liabilities, in more detail
Across the 4 fiscal years on record (2022–2025), the highest was £50.05B in fiscal 2022 and the lowest £45.16B in fiscal 2025.
Total liabilities by fiscal year
GSK total liabilities, year by year
| Fiscal year | Total liabilities | Change | Year ended |
|---|---|---|---|
| 2025 | £45.16B | 2.6% down | |
| 2024 | £46.38B | 0.4% up | |
| 2023 | £46.21B | 7.7% down | |
| 2022 | £50.05B | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.
How to read it
It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.
Total liabilities at health care companies of similar size
| Company | Total liabilities | Fiscal year |
|---|---|---|
| Sanofi SNY | €55.10B | 2025 |
| GSK GSK | £45.16B | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
GSK, figure by figure
- GSK market cap
- GSK revenue
- GSK earnings
- GSK earnings per share (EPS)
- GSK P/E ratio
- GSK P/S ratio
- GSK P/B ratio
- GSK free cash flow
- GSK operating margin
- GSK dividend
- GSK shares outstanding
- GSK total debt
- GSK cash on hand
- GSK total assets
- GSK net assets (shareholders' equity)
- GSK return on equity (ROE)
- GSK return on invested capital (ROIC)
GSK (GSK) overview: price, valuation and scorecardAll health care companies by market value
GSK total liabilities: questions and answers
How large are GSK's total liabilities?
GSK had total liabilities of £45.16B at the end of fiscal 2025 (December 31, 2025). That is 2.6% lower than the £46.38B of fiscal 2024.
What are the highest and lowest total liabilities figures on record for GSK?
Across the 4 fiscal years on record (2022–2025), the highest was £50.05B in fiscal 2022 and the lowest £45.16B in fiscal 2025.
How is GSK's total liabilities calculated?
Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For GSK it is on record here for 4 fiscal years, 2022 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: total liabilities
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “GSK (GSK) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/GSK/total-liabilities
Underlying data: Yahoo Finance.